Research
11/5/2013

Lead Investigator, Dr. Susan McElroy: Positive Top-line Results Shown for Vyvanse® Capsules in Adults with Binge Eating Disorder

Positive Top-line Results Shown for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) in Adults with Binge Eating Disorder
10/24/2013

Dr. John Hawkins Named Principal Investigator for Clinical Trial of Non-drug Depression Treatment

Technology capable of reaching deeper brain areas may provide relief of symptoms for patients resistant to medication
9/27/2013

Lindner Center of HOPE Chief Research Officer to present at “IX International Symposium on Psychopathology and Clinical Psychiatry” in Santiago, Chile

 Mason, OHSusan L. McElroy, MD, Lindner Center of HOPE, Chief Research Officer and University of Cincinnati College of Medicine, Professor of Psychiatry and Neuroscience, will present at “IX International Symposium on Psychopathology and Clinical Psychiatry” at Clinica Alemana in Santiago, Chile on October 4th and 5th, 2013.
9/24/2013

Lindner Center of HOPE Serves as Site for TMS Trial

Recruitment began this month for a prospective, double-blind, randomized, parallel-group, sham-controlled feasibility trial of multi-coil Transcranial Magnetic Stimulation (TMS) for the treatment of major depressive disorder. Lindner Center of HOPE is participating in this trial. Visit thedepressiontrial.com, to learn more.
8/9/2013

Bipolar Disorder evolves differently in patients who binge eat, according to a study in which Lindner Center of HOPE participated

Bipolar disorder evolves differently in patients who also binge eat, a study by Mayo Clinic, the Lindner Center of HOPE and the University of Minnesota found.
6/12/2013

NNDC Study Shows TMS Demonstrates Efficacy In Clinical Practice

 NNDC Study Shows TMS Demonstrates Efficacy In Clinical Practice
6/12/2013

Binge Eating Medication Trial, Led by The Research Institute at Lindner Center of HOPE, Shows Promising Results according to MedPage Today

Binge Eating Medication Trial, Led by The Research Institute at Lindner Center of HOPE, Shows Promising Results according to MedPage Today
8/27/2012

One Mind for Research

The Silent Wounds of War

Invisible but devastating, traumatic brain injury and post-traumatic stress leave a tragic mark on our soldiers, our veterans, and members of our community.

4/27/2012

The Research Institute at Lindner Center of HOPE Leading Encouraging Study for Binge Eating Disorder Treatment

Shire Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults with Binge Eating Disorder

Company Plans to Conduct Additional Analyses of These Preliminary Data

6/15/2011

A Debate Amongst Experts To Expand the Bipolar Spectrum

Is it a Problematic Concept?

At the Annual American Psychiatric Association (APA) meeting held May 14-18, Dr. Susan McElroy, Chief Research Officer at Lindner Center of HOPE presented research evidence supporting the broadening of the concept of Bipolar Disorder.  Colleagues Dr. Mari Maj, from Italy and Dr. Stephen Strakowski, Professor and Chair at University of Cincinnati Department of Psychiatry & Behavioral Health argued that the diagnostic criteria should not be broadened.  

5/10/2011

OCD Medical Research Study Looks at First New Medication in 20 Years

Adjunctive therapy being examined for those who have not responded to SSRI treatment

Adults who struggle with Obsessive Compulsive Disorder, even with treatment, can participate in a clinical trial to help doctors evaluate an investigational medication

4/20/2011

Experts Launch Cincinnati Mood Disorders Consortium

Collaboration will bring together regional, national and international experts to improve research, clinical care and education surrounding mood disorders.

Regional and international experts in mood disorders from University of Cincinnati Academic Health Center, Lindner Center of HOPE and Cincinnati Children’s Hospital Medical Center have joined to form the Cincinnati Mood Disorders Consortium (CMDC).

2/28/2011

Lindner Center of HOPE Seeks Participants for New Bipolar Medication Research Trial

Research Institute at Lindner Center of HOPE, in affiliation with the University of Cincinnati, College of Medicine, is conducting a Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness), research study to compare the effectiveness of two medications used to treat bipolar disorder.

 

7/1/2010

Dr. Susan McElroy comments on results from a 24-week open-label study of Contrave

Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) today announced results from a 24-week open-label study demonstrating that treatment with Contrave(R) resulted in significant improvements in depressive symptoms that was accompanied by weight loss and improved control of eating in overweight and obese patients with major depression.

7/31/2009

Lindner Center of HOPE conducts adolescent bipolar depression study

The Research Institute at Lindner Center of HOPE is currently investigating a treatment option for bipolar depression in adolescents ages 10 to 17.

As part of a global study, the Center’s findings will contribute to data being collected around the world proving or disproving the efficacy of a medication, currently on the market for adults, in adolescents.  The medication is considered investigational and is not approved by the United States Food & Drug Administration for this indication.